SCHEMBL4657142

SCHEMBL4657142

CCC(C#N)c1cc([N+](=O)[O-])ccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
TSHR P16473 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
CYP3A4 P08684 3/20 0.45
KMT2A Q03164 1/20 0.39
PDE2A O00408 1/20 0.39
PDE5A O76074 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
APEX1 P27695 1/20 0.39
PDE4A P27815 1/20 0.39
BLM P54132 1/20 0.39
PDE1B Q01064 1/20 0.39
PMP22 Q01453 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE7A Q13946 1/20 0.39
PDE1C Q14123 1/20 0.39
PDE7B Q9NP56 1/20 0.39
VCAM1 P19320 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656744 0.84 VCAM1 (0.51) ALDH1A1TDP1KMT2AVCAM1GAA
SCHEMBL4658078 0.84 ALDH1A1 (0.40) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL31406340 0.80 ALDH1A1 (0.53) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL16971077 0.80 ALDH1A1 (0.53) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL5050017 0.76 ALDH1A1 (0.45) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL4657724 0.75 ALDH1A1 (0.48) ALDH1A1TSHRTDP1KMT2ALMNA
SCHEMBL12929973 0.74 ALDH1A1 (0.62) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL4658986 0.73 ALDH1A1 (0.49) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL18993967 0.73 ALDH1A1 (0.60) ALDH1A1TSHRTDP1CYP3A4KMT2A
SCHEMBL21470479 0.73 ALDH1A1 (0.60) ALDH1A1TSHRTDP1CYP3A4PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD ALDH1A1 159/4885TSHR 4208/4885TDP1 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.